arrow
A

Antonio Bossi

Humanitas Gavazzeni
H指数:27
被引数:4,431

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world effectiveness of denosumab compared to teriparatide in patients with severe osteoporosis

与特立帕肽相比,地诺单抗在重度骨质疏松症患者中的真实世界有效性

2026-03-180
OAAI
EFFECTIVENESS OF BISPHOSPHONATES AND DENOSUMAB ON RISK OF VERTEBRAL FRACTURES IN PROSTATE CANCER PATIENTS UNDER ANDROGEN-DEPRIVATION THERAPIES: A REAL-WORLD PROSPECTIVE STUDY

双膦酸盐和地诺单抗对接受雄激素剥夺治疗的 prostate cancer 患者发生椎体骨折风险的有效性:一项真实世界前瞻性研究

2025-09-300
PRE
Unraveling the Puzzle of Bone Health in Klinefelter Syndrome: Association Between DXA-Derived Lumbar Bone Strain Index and Body Composition Parameters in a Single Center Cohort

解开克氏综合征骨骼健康之谜:单中心队列中由DXA衍生腰椎骨应变指数与身体成分参数之间的关联

2025-07-060
PRE
Anogenital distance in Klinefelter syndrome: A case-control study

Klinefelter综合征的肛门生殖器距离: 一项病例对照研究

2025-03-010
PRE
Bone-active drugs in premenopausal women with breast cancer under hormone-deprivation therapies

激素剥夺治疗下绝经前乳腺癌妇女的骨活性药物

2024-07-261
PRE
Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors

Denosumab改善小梁骨评分与降低暴露于芳香化酶抑制剂的女性骨折风险的关系

2023-08-178
PRE
Long-term kidney and systemic effects of calorie restriction in overweight or obese type 2 diabetic patients (C.Re.SO 2 randomized controlled trial)
2022-03-0112
OAAI
Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trial

肾小球阻力预测无明显肾病的2型糖尿病患者的长期GFR下降: DEMAND试验的纵向亚组分析

2021-10-143
PREAI
Pasta Consumption and Connected Dietary Habits: Associations with Glucose Control, Adiposity Measures, and Cardiovascular Risk Factors in People with Type 2 Diabetes-TOSCA.IT Study

意大利面消费和相关的饮食习惯: 与2型Diabetes-TOSCA.IT患者的血糖控制,肥胖措施和心血管危险因素的关联研究

2019-12-3019
OAAI
Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trial
2019-02-2219
PREAI